Wilhelm Haverkamp

Electrophysiologic characterization of the antipsychotic drug sertindole in a rabbit heart model of torsade de pointes: low torsadogenic potential despite QT prolongation.

Cardiac autonomic dysfunction in Brugada syndrome.

Dilated cardiomyopathy in mice deficient for the lysosomal cysteine peptidase cathepsin L.

Body surface potential mapping in patients with Brugada syndrome: right precordial ST segment variations and reverse changes in left precordial leads.

Physician-induced torsade de pointes--therapeutic implications.

Genotype-phenotype relationship in Brugada syndrome: electrocardiographic features differentiate SCN5A-related patients from non-SCN5A-related patients.

A novel nonfluoroscopic catheter visualization system (LocaLisa) to reduce radiation exposure during catheter ablation of supraventricular tachycardias.

Identification and functional characterization of a novel KCNE2 (MiRP1) mutation that alters HERG channel kinetics.

[Atrial fibrillation: molecular biology bases].

Body surface area of ST elevation and the presence of late potentials correlate to the inducibility of ventricular tachyarrhythmias in Brugada syndrome.

Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes.

Anterior-posterior versus anterior-lateral electrode positions for external cardioversion of atrial fibrillation: a randomised trial.

Prolonged action potential durations, increased dispersion of repolarization, and polymorphic ventricular tachycardia in a mouse model of proarrhythmia.

Molecular mechanisms of inherited ventricular arrhythmias.

Advances for treating in-hospital cardiac arrest: safety and effectiveness of a new automatic external cardioverter-defibrillator.

Molecular site of action of the antiarrhythmic drug propafenone at the voltage-operated potassium channel Kv2.1.

Recurrent syncope in a young patient with long QT syndrome: possible relationship of atrioventricular nodal re-entrant tachycardia with neurally mediated spells?

Antiarrhythmic therapy in heart failure.

Amiodarone-induced postrepolarization refractoriness suppresses induction of ventricular fibrillation.

Effect of pacing and mexiletine on dispersion of repolarisation and arrhythmias in DeltaKPQ SCN5A (long QT3) mice.

Effect of sotalol and acute ventricular dilatation on action potential duration and dispersion of repolarization after defibrillation shocks.

In vivo recording of monophasic action potentials in awake dogs.

The ajmaline challenge in Brugada syndrome: diagnostic impact, safety, and recommended protocol.

Endocardial mapping of right ventricular outflow tract tachycardia using noncontact activation mapping.

Cardiac and ocular pathologies in a mouse model of mucopolysaccharidosis type VI.

Electrical alternans in long QT syndrome resembling a Brugada syndrome pattern.

Prolonged atrial action potential durations and polymorphic atrial tachyarrhythmias in patients with long QT syndrome.

Genetic variations of KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 in drug-induced long QT syndrome patients.

Sodium channel gene (SCN5A) mutations in 44 index patients with Brugada syndrome: different incidences in familial and sporadic disease.

Images in cardiovascular medicine. Life-threatening neonatal arrhythmia: successful treatment and confirmation of clinically suspected extreme long QT-syndrome-3.

Comparison of the in vitro electrophysiologic and proarrhythmic effects of amiodarone and sotalol in a rabbit model of acute atrioventricular block.

Phytanic acid accumulation is associated with conduction delay and sudden cardiac death in sterol carrier protein-2/sterol carrier protein-x deficient mice.

Transmural dispersion of repolarization as a key factor of arrhythmogenicity in a novel intact heart model of LQT3.

Atypical antipsychotics: from potassium channels to torsade de pointes and sudden death.

Electrophysiological effects of flecainide and sotalol in the human atrium during persistent atrial fibrillation.

True right bundle branch block masking the typical ECG in Brugada syndrome.

Implantable cardioverter-defibrillator therapy in patients with congenital long-QT syndrome: a long-term follow-up.

[Long QT syndrome and Brugada syndrome. Drugs, ablation or ICD?].

QTc interval prolongation and antipsychotic drug treatments: focus on sertindole.

Sudden infant death syndrome and long QT syndrome: an epidemiological and genetic study.

Drug-induced sudden cardiac death.

QT prolongation and syncope with methadone, doxepin, and a beta-blocker.

[Arrhythmogenic right ventricular cardiomyopathy].

Idiopathic left ventricular tachycardia: procedural and fluoroscopy time saving ablation using LocaLisa navigation system.

Reduced repolarization reserve due to anthracycline therapy facilitates torsade de pointes induced by IKr blockers.

Electrocardiographic risk stratification in families with congenital long QT syndrome.

Optimization of cardiac resynchronization guided by Doppler echocardiography: haemodynamic improvement and intraindividual variability with different pacing configurations and atrioventricular delays.

Electrical storm: still a cryptogenic phenomenon?

Cardiovascular characterization of Pkd2(+/LacZ) mice, an animal model for the autosomal dominant polycystic kidney disease type 2 (ADPKD2).

Dopamine agonists and the risk of cardiac-valve regurgitation.

Proarrhythmia as a class effect of quinolones: increased dispersion of repolarization and triangulation of action potential predict torsades de pointes.

[Congenital long QT syndrome].

Sustained monomorphic ventricular tachycardia after adenosine infusion.

Optimal heart failure therapy and successful cardioversion in heart failure patients with atrial fibrillation.

Bisoprolol vs. carvedilol in elderly patients with heart failure: rationale and design of the CIBIS-ELD trial.

Sequence analysis of myozenin 2 in 438 European patients with familial hypertrophic cardiomyopathy.

A missense variant in desmoglein-2 predisposes to dilated cardiomyopathy.

Recovery from peripartum cardiomyopathy after treatment with bromocriptine.

Coronary artery occlusion due to lead insertion into the right ventricular outflow tract.

Atrial Arrhythmias in long-QT syndrome under daily life conditions: a nested case control study.

Induction of ventricular fibrillation rather than ventricular tachycardia predicts tachyarrhythmia recurrences in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillator for secondary prophylaxis.

Genetic deletion of arginine 14 in phospholamban causes dilated cardiomyopathy with attenuated electrocardiographic R amplitudes.

Arrhythmogenic right ventricular cardiomyopathy: diagnosis and risk stratification.

Mutational analysis of the PITX2 and NKX2-5 genes in patients with idiopathic atrial fibrillation.

[Limits and scopes of invasive risk stratification. Do we still need programmed ventricular stimulation?].

Mutations in the cardiac transcription factor GATA4 in patients with lone atrial fibrillation.

Gold vs. platinum-iridium tip catheter for cavotricuspid isthmus ablation: the AURUM 8 study.

Steerable versus nonsteerable sheath technology in atrial fibrillation ablation: a prospective, randomized study.

Findings and outcome of fluoroscopic visualization of the oesophageal course during catheter ablation of atrial fibrillation.

Left atrial systolic and diastolic dysfunction in heart failure with normal left ventricular ejection fraction.

Right ventricular myocardial systolic and diastolic dysfunction in heart failure with normal left ventricular ejection fraction.

Self-rated health predicts adverse events during β-blocker treatment: the CIBIS-ELD randomised trial analysis.

Ventricular tachycardia as the first manifestation of cardiac sarcoidosis.

Role of implantable cardioverter defibrillator therapy in patients with acquired long QT syndrome: a long-term follow-up.

Safety aspects of deep sedation during catheter ablation of atrial fibrillation.

N-terminal pro-B-type natriuretic peptide and long-term mortality in non-ischaemic cardiomyopathy.

In vitro modeling of ryanodine receptor 2 dysfunction using human induced pluripotent stem cells.

Risk of cardiac valve regurgitation with dopamine agonist use in Parkinson's disease and hyperprolactinaemia: a multi-country, nested case-control study.

Clinical cardiac safety profile of nilotinib.

Polymorphic ventricular tachycardia in a patient with herpes encephalitis.

Determinants of mortality in patients with heart failure and atrial fibrillation during long-term follow-up.

Cost-effectiveness of paclitaxel-coated balloon angioplasty and paclitaxel-eluting stent implantation for treatment of coronary in-stent restenosis in patients with stable coronary artery disease.

Myocardial systolic and diastolic consequences of left ventricular mechanical dyssynchrony in heart failure with normal left ventricular ejection fraction.

"Largest amplitude ablation" is the optimal approach for typical atrial flutter ablation: a subanalysis from the AURUM 8 study.

Absent proximal right coronary artery with a fistula into the pulmonary vein.

Molecular insights into arrhythmogenic right ventricular cardiomyopathy caused by plakophilin-2 missense mutations.

Update on the cardiac safety of moxifloxacin.

Myocardial systolic and diastolic performance derived by 2-dimensional speckle tracking echocardiography in heart failure with normal left ventricular ejection fraction.

Rate of cardiac arrhythmias and silent brain lesions in experienced marathon runners: rationale, design and baseline data of the Berlin Beat of Running study.

Potential lifetime cost-effectiveness of catheter-based renal sympathetic denervation in patients with resistant hypertension.

Clinical significance of the assessment of the systolic and diastolic myocardial function of the left atrium in patients with paroxysmal atrial fibrillation and low CHADS(2) index treated with catheter ablation therapy.

Determinants of change in quality of life in the Cardiac Insufficiency Bisoprolol Study in Elderly (CIBIS-ELD).

Differences in clinical and echocardiographic parameters between paroxysmal and persistent atrial flutter in the AURUM 8 study: targets for prevention of persistent arrhythmia?

Effects of deep sedation on cardiac electrophysiology in patients undergoing radiofrequency ablation of supraventricular tachycardia: impact of propofol and ketamine.

Incidence, prevalence, and antithrombotic management of atrial fibrillation in elderly Germans.

Cost-effectiveness of cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary artery disease in Germany.

Cost-effectiveness of paclitaxel-coated balloon angioplasty in patients with drug-eluting stent restenosis.

Atrial fibrillation-induced cardiac troponin I release.

[Project report: Development of log books for the medical practical year at the Charité].

Variations in the human soluble epoxide hydrolase gene and recurrence of atrial fibrillation after catheter ablation.

Epidemiology of symptomatic drug-induced long QT syndrome and Torsade de Pointes in Germany.

Polymorphic ventricular tachycardia after amiodarone infusion in extreme tachycardia-bradycardia-syndrome.

Improvement of cerebral oxygen saturation after successful electrical cardioversion of atrial fibrillation.

Deep sedation during catheter ablation for atrial fibrillation in elderly patients.

The anticipatory proportion as an indicator of language impairment in early-stage cognitive disorder in the elderly.

Impact of selection criteria on recruitment in an interventional stroke trial.

Minimal and deep sedation during ablation of ventricular tachycardia.

[In Process Citation].

[Long QT-syndromes: diagnosis and genetics].

[Brugada syndrome. Current clinical aspects and risk stratification].

Multidirectional global left ventricular systolic function in normal subjects and patients with hypertension: multicenter evaluation.

Robotic ablation of atrial fibrillation with a new remote catheter system.

The use of direct oral anticoagulants for stroke prevention in atrial fibrillation: a study on physicians' perspective and preferences.

Mapping of the left-sided phrenic nerve course in patients undergoing left atrial catheter ablations.

Acute decrease of cerebral oxygen saturation during rapid ventricular and supraventricular rhythm: a pilot study.

Contact force mapping during catheter ablation for atrial fibrillation: procedural data and one-year follow-up.

Potential cost-effectiveness of therapeutic drug monitoring in patients with resistant hypertension.

An unusual case of impossible communication between an ICD and programmer.

Global cardiac alterations detected by speckle-tracking echocardiography in Fabry disease: left ventricular, right ventricular, and left atrial dysfunction are common and linked to worse symptomatic status.

Normal values and clinical relevance of left atrial myocardial function analysed by speckle-tracking echocardiography: multicentre study.

Mid-regional proadrenomedullin levels predict recurrence of atrial fibrillation after catheter ablation.

Performance of chest compressions with the use of a new audio-visual feedback device: a randomized manikin study in health care professionals.

Structural and functional cardiac analyses using modern and sensitive myocardial techniques in adult Pompe disease.

Incidence, prevalence and 1-year all-cause mortality of heart failure in Germany: a study based on electronic healthcare data of more than six million persons.

Left Atrial Appendage Conduction Jump for Real-Time Evaluation of Conduction Block Over the Anterior Mitral Annulus Line.

Torsade de pointes tachycardia in a patient on dronedarone therapy.

Approaches to catheter ablation for persistent atrial fibrillation.